GSP3

GSP3 is an investigational oral capsule tested as an intervention for weight loss in overweight and obese adult subjects. It was evaluated in a randomized, placebo-controlled clinical trial assessing its effects on body weight, waist circumference, fat mass, appetite, metabolic parameters, and safety outcomes over a 14-week period. The precise active ingredient, mechanism of action, or composition of GSP3 was not disclosed in the clinical trial record, but it was administered in oral capsule form at either 3 or 5 capsules of 750 mg each, twice daily before meals, compared to placebo (microcrystalline cellulose).